c/prof dominic mallon - university of wa & dept of health wa - state perspectives: what’s...
DESCRIPTION
C/Prof Dominic Mallon delivered the presentation at 2014 National Pathology Forum. The National Pathology Forum 2014 featured case studies on innovative testing methods in the fields of genetics, biobanking and PoCT. The highly interactive nature of the National Pathology Forum allowed delegates to network with each other and converse with the speakers asking questions as part of debates, industry roundtables, short workshops and panel discussions. For more information about the event, please visit: http://bit.ly/pathology14TRANSCRIPT
PathWest Where We Are Now and the Challenges Ahead
Dr Dominic MallonChief Pathologist
History
• Formed 15th July, 2005 as an operational division
within the Metropolitan Health Service
• Now in our 10th year
• Amalgamation of PathCentre (QE2) and the
Metropolitan Health Service pathology laboratories at
Royal Perth, Fremantle, Princess Margaret and King
Edward Memorial Hospitals
PathWest - Fast Facts
• ~10 million panels registered pa (15 million tests)
• 5-10% increase in tests pa 2005 - 2014
• ~2000 staff (1600 FTE)
• Facilities
• 5 Teaching Hospital Laboratories
– 2.5 by end of 2015
• 23 Branch Laboratories
• 56 Collection Centres
• Operational budget $261M for 2013/14
Teaching and Regional
Hospitals (Health Dept of
Western Australia)
Community
and Regional
Medical
Practitioners
(Medicare)
Western
Australian
Police
Commercial
Clients
Universities: Esp.
UWA,
Curtin University
Major External Stakeholders
State
Coroner
PATHWEST MAJOR PROJECTS 2010 – 2015 FINANCIAL YEARS
2010 2011 2012 2013 2014 2015
LIS +++
ABF
QE2 (1)
FSH (1)
POCT
PCH
NRPH
School
PaLM
Grey = Low Activity
Blue = Medium Activity
Red = High Activity
Added Internal Challenges - 2014
• Maintaining services at tertiary hospitals with
departing analytical infrastructure (RPH, PMH, FH)
– Enhanced Pre-analytical processes, ICT
– Preserved post-analytical input and support for
research
• Maintaining Paediatric Expertise within the
consolidated laboratory at QE2 site
Added External Challenges - 2014
• Regionalisation of Clinical Services in WA
– Mismatches in demand vs capacity
– Understanding Pathology costs in an ABF environment
• Demands for innovation esp in molecular biology
– Making the case for new areas of diagnostic testing
• Working with clinicians to make the value proposition
– Establishment of the diagnostic “pipeline”
• Generation, management, QC, interpretation and storage of the data
• Flow of information across departments eg AP, AP molecular,
translational pathology, genomics laboratories,
Low and High complexity service delivery
∙Interns to Consultants
∙Comprehensive repertoire
Reference Laboratories
∙Comprehensive access
After Hours
Rural and Remote
Point of Care
•Cost Recovery pricing
•Integral Clinical Service
Membership of Exec and other Operational Committees
Performance aligned with ACHS accreditation requirements
Clinical care and Consultation
•Integrated Academic activities
Appropriate use of diagnostic lab
Teaching
Training
Translational Research
Development of new tests
Ultimate Challenge – Demonstrating
the Value of Laboratory Medicine